UNSPSC 51384204: Piketoprofen

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 362QBC4NL0. European Medicines Agency schedules Piketoprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09832MIG. Piketoprofen generally arises in the molecular formula C22H20N2O2.

UNSPSC 51384204 Piketoprofen, a Commodity code, does not align with the recent state and local procurement activity posted under this designation. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and drug deactivation systems for community health initiatives, a scope that falls outside the pharmaceutical anti-inflammatory product category that piketoprofen represents. State and local governments buy piketoprofen as a pharmaceutical active ingredient or finished medication, typically for health departments, correctional facilities, emergency medical services, or public health programs; the recent activity in this code, however, shows no procurement aligned to that scope.

Seminole County released the naloxone and drug deactivation systems IFB on June 30, 2026, with a response deadline of July 26, 2026, seeking 1,900 units of naloxone and 800 deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement includes standard compliance requirements (E-Verify, drug-free workplace certification, workers' compensation and general liability insurance) and carries a two-year initial term with one-year renewal option. While the posting indicates potential FEMA funding and associated federal compliance obligations, the opportunity itself addresses harm-reduction and overdose-response supplies rather than piketoprofen or similar anti-inflammatory pharmaceuticals. The code shows minimal recent relevant activity; firms pursuing state and local pharmaceutical procurement should monitor whether future piketoprofen demand emerges under this or related pharmaceutical-services codes, as the current posting represents a category mismatch rather than actionable demand signal for this commodity.